Shares of Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $126.25.
A number of brokerages have weighed in on BLLN. Weiss Ratings lowered Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research note on Thursday, October 8th. Wall Street Zen cut shares of Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Guggenheim raised their price objective on shares of Billiontoone from $125.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. JPMorgan Chase & Co. dropped their price objective on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a report on Thursday, August 6th. Finally, Canaccord Genuity Group initiated coverage on shares of Billiontoone in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 target price for the company.
Check Out Our Latest Research Report on BLLN
Billiontoone Trading Down 0.1%
NASDAQ:BLLN opened at $114.00 on Thursday. Billiontoone has a 1 year low of $61.96 and a 1 year high of $150.44. The stock’s fifty day moving average price is $102.98 and its two-hundred day moving average price is $96.43. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The company has a market cap of $5.38 billion and a P/E ratio of 162.86.
Billiontoone (NASDAQ:BLLN – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The firm had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. As a group, analysts expect that Billiontoone will post 0.80 EPS for the current year.
Insider Activity
In other Billiontoone news, CTO David Tsao sold 20,000 shares of the stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $98.77, for a total transaction of $1,975,400.00. Following the transaction, the chief technology officer directly owned 1,000 shares in the company, valued at $98,770. This trade represents a 95.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of Billiontoone stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the transaction, the chief executive officer directly owned 20,000 shares in the company, valued at $2,739,000. This trade represents a 61.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 249,025 shares of company stock worth $27,387,892. 50.22% of the stock is currently owned by insiders.
Institutional Trading of Billiontoone
Hedge funds have recently added to or reduced their stakes in the business. Wasatch Advisors LP increased its holdings in shares of Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after buying an additional 148,446 shares during the period. Emerald Advisers LLC lifted its stake in shares of Billiontoone by 26.8% in the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after acquiring an additional 50,613 shares during the last quarter. Emerald Mutual Fund Advisers Trust lifted its stake in shares of Billiontoone by 11.9% in the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock valued at $10,436,000 after acquiring an additional 14,072 shares during the last quarter. Perceptive Advisors LLC boosted its holdings in Billiontoone by 26.1% during the 1st quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock valued at $7,248,000 after acquiring an additional 19,000 shares during the period. Finally, Renaissance Technologies LLC purchased a new stake in Billiontoone during the 1st quarter valued at about $4,046,000.
About Billiontoone
BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.
The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.
Recommended Stories
- Five stocks we like better than Billiontoone
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
